Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Neuroligin-1 is altered in Alzheimer’s disease

Jonathan Brouillette, PhD, University of Montreal, Montreal, Quebec, Canada, outlines a study investigating whether neuroligin-1 (NLGN1) is altered in the hippocampus of Alzheimer’s disease (AD) patients as well as whether it modulates cognitive functions during Aβo-driven neurodegeneration. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).